Clinical Trial: ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07737964) titled 'ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.' on July 27.

Brief Summary: Acute congestion is common in patients with heart failure (HF) and is associated with impaired renal function, reduced quality of life, hospital readmissions, and mortality. Current guidelines recommend optimal decongestion using diuretic therapy, mainly loop diuretics. Although acetazolamide has recently demonstrated efficacy in hospitalized patients, its role in ambulatory patients managed through remote telemonitoring remains to be established. This study aims to evaluate the efficacy of oral acetazolamide added to c...